Fujirebio, a subsidiary of H.U. Group Holdings, acquired ADx NeuroSciences NV for 40 million euros. ADx NeuroSciences becomes a wholly owned subsidiary of Fujirebio Europe NV. The deal is expected to close in July 2022.
ENDATA